Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 14 | 64093374 | stop gained | G/A | snv | 8.5E-02 | 8.9E-02 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||||
|
1.000 | 14 | 64107608 | splice donor variant | G/A;T | snv | 4.0E-06 | 7.0E-06 |
|
0.700 | 0 | |||||||||||
|
14 | 64160241 | intron variant | C/T | snv | 1.6E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.925 | 0.040 | 14 | 64180928 | intron variant | T/G | snv | 0.12 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.040 | 14 | 64180928 | intron variant | T/G | snv | 0.12 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 14 | 64210033 | missense variant | C/G;T | snv | 4.0E-06; 4.8E-03 |
|
0.800 | 1.000 | 1 | 2007 | 2007 | |||||||||
|
14 | 64212580 | intron variant | T/G | snv | 5.6E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
1.000 | 0.080 | 14 | 64213242 | intron variant | A/G | snv | 0.63 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.700 | 1.000 | 2 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 14 | 64214130 | intron variant | A/C;G;T | snv |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.800 | 1.000 | 2 | 2012 | 2017 | ||||||||
|
1.000 | 0.040 | 14 | 64219304 | missense variant | C/T | snv | 4.0E-06 | 1.4E-05 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
1.000 | 0.040 | 14 | 64219489 | intron variant | A/G;T | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
1.000 | 0.120 | 14 | 64225135 | intron variant | C/T | snv | 5.6E-02 |
|
Neoplasms; Male Urogenital Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 14 | 64225321 | missense variant | T/A;C;G | snv | 3.2E-05; 4.0E-06 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.040 | 14 | 64225912 | 3 prime UTR variant | G/A;C | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
14 | 64226667 | intron variant | G/A | snv | 0.25 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.827 | 0.200 | 14 | 64227153 | 3 prime UTR variant | G/C;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.827 | 0.200 | 14 | 64227153 | 3 prime UTR variant | G/C;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.827 | 0.200 | 14 | 64227153 | 3 prime UTR variant | G/C;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.827 | 0.200 | 14 | 64227153 | 3 prime UTR variant | G/C;T | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.827 | 0.200 | 14 | 64227153 | 3 prime UTR variant | G/C;T | snv |
|
0.010 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
0.827 | 0.200 | 14 | 64227153 | 3 prime UTR variant | G/C;T | snv |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.925 | 0.080 | 14 | 64227194 | 3 prime UTR variant | C/T | snv | 2.4E-02 |
|
Neoplasms; Male Urogenital Diseases | 0.710 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.080 | 14 | 64227194 | 3 prime UTR variant | C/T | snv | 2.4E-02 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.080 | 14 | 64227364 | 3 prime UTR variant | T/C | snv | 0.17 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | < 0.001 | 1 | 2009 | 2009 | |||||||
|
0.925 | 0.080 | 14 | 64227364 | 3 prime UTR variant | T/C | snv | 0.17 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | < 0.001 | 1 | 2009 | 2009 |